Aemetis (NASDAQ:AMTX – Get Free Report) is set to release its earnings data before the market opens on Tuesday, November 12th. Analysts expect Aemetis to post earnings of ($0.47) per share for the quarter.
Aemetis Trading Up 1.1 %
Shares of AMTX opened at $2.83 on Thursday. The firm has a market capitalization of $133.57 million, a price-to-earnings ratio of -2.43 and a beta of 1.23. The firm’s 50-day moving average price is $2.60 and its 200-day moving average price is $3.06. Aemetis has a 1-year low of $2.10 and a 1-year high of $7.03.
Wall Street Analysts Forecast Growth
AMTX has been the subject of several recent analyst reports. StockNews.com raised Aemetis to a “sell” rating in a research report on Wednesday, July 31st. Ascendiant Capital Markets cut their price target on shares of Aemetis from $20.00 to $19.00 and set a “buy” rating on the stock in a report on Tuesday, September 3rd. HC Wainwright restated a “buy” rating and issued a $28.00 price objective on shares of Aemetis in a report on Friday, August 2nd. Truist Financial reissued a “hold” rating and issued a $3.50 target price (down previously from $4.00) on shares of Aemetis in a report on Wednesday, July 31st. Finally, UBS Group decreased their target price on Aemetis from $8.25 to $7.75 and set a “buy” rating for the company in a research report on Monday, August 19th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, Aemetis currently has an average rating of “Moderate Buy” and a consensus target price of $12.95.
About Aemetis
Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.
Recommended Stories
- Five stocks we like better than Aemetis
- Pros And Cons Of Monthly Dividend Stocks
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
- Consumer Staples Stocks, Explained
- Atlassian Is Up +60% in Three Months—What’s Causing the Rally?
- What is a buyback in stocks? A comprehensive guide for investors
- 2 Reasons To Like Coinbase After The Election, 1 to Still Avoid
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.
